当前位置:药药网 / 数据中心 / 生物制药海外临床研究状况
A Study to Evaluate the Efficacy of IBI939 in Combination With Sintilimab in Patients With Advanced NSCLC
标题(英文)
A Study to Evaluate the Efficacy of IBI939 in Combination With Sintilimab in Patients With Advanced NSCLC
干预
Biological: IBI939|Biological: Sintilimab